(Q50579974)

15 March 2018

title

Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid. (English)

1 reference

15 March 2018

1 reference

1

1 reference

15 March 2018

Irene Crespo

2

1 reference

15 March 2018

José L. Mauriz

4

1 reference

15 March 2018

María J. Tuñón

6

1 reference

15 March 2018

Javier González-Gallego

7

1 reference

15 March 2018

author name string

Nelson A Kretzmann

3

1 reference

15 March 2018

Norma Marroni

5

1 reference

15 March 2018

language of work or name

English

0 references

publication date

21 April 2010

1 reference

15 March 2018

published in

Journal of Nutrition

1 reference

15 March 2018

volume

140

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

page(s)

1065-1071

1 reference

15 March 2018

The immunological and genetic basis of inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Fibrogenesis in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Intestinal fibrosis in IBD--a dynamic, multifactorial process

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Intestinal subepithelial myofibroblasts in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Platelet-derived growth factor and its receptors are expressed in areas of both active inflammation and active fibrosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Regulative potential of glutamine--relation to glutathione metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

The use of glutamine in the treatment of gastrointestinal disorders in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Potential for amino acids supplementation during inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Animal models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Smad7 in TGF-beta-mediated negative regulation of gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Targeting Smads to restore transforming growth factor-beta signaling and regulatory T-cell function in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Glutathione regulates transforming growth factor-beta-stimulated collagen production in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

TNFalpha is required for cholestasis-induced liver fibrosis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121525

21 January 2018

Identifiers

DOI

10.3945/JN.110.121525

1 reference

15 March 2018

1 reference

15 March 2018